Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia

Archives of General Psychiatry

Volumn 58, Issue 7, 2001, Pages 706-707

  Jackson, R S ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; CASE REPORT; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; PATIENT MONITORING; SCHIZOPHRENIA; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0034932362     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.7.706     Document Type: Letter

References (3)

1. The expert consensus guideline series: Treatment of schizophrenia
2. Continuing clozapine despite neutropenia
3. Genetic leukopenia in people of African origin